Healthcare

Sale of a portfolio of poultry vaccines for the Mexican market to Lapisa

October 2017: Capitalmind advised Boehringer Ingelheim on the carve-out of Gallimune 302 and Volvac, a portfolio of poultry vaccines for the Mexican market, and the subsequent sale to Lapisa

read more

Sale of Previcox South Korea, a Boehringer Ingelheim product, to Green Cross Veterinary Products

October 2017: Capitalmind advised Boehringer Ingelheim on the carve-out of Previcox, an animal health product for the South Korean market, and the subsequent sale to Green Cross Veterinary Products

read more

Sale of Bertin Pharma’s pharmaceutical and biotech service businesses to Oncodesign

August 2017: Capitalmind advised CNIM Group on the sale of Bertin Pharma’s pharmaceutical and biotech service businesses to Oncodesign

read more

Sale of Bertin Pharma’s pharmaceutical development activities to Amatsigroup

August 2017: Capitalmind advised CNIM Group on the sale of Bertin Pharma’s pharmaceutical development activities to Amatsigroup (Eurofins)

read more

DermaClin acquires MNC

January 2017: Capitalmind advised the management of DermaClin Deutschland GmbH on the debut acquisition for a buy&build concept in the field of medical and aesthetic dermatology funded by Ufenau Capital Partners

read more
Page 1 of 512345